Open tender · Germany · Cn Standard
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Pegfilgrastim (ATC-Code L03AA13).
The work
Conclusion of a non-exclusive discount contract for the drug Pegfilgrastim (ATC-Code L03AA13) in an 'open-house-model' from 01.02.2025 to 31.01.2027.
- Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) with a seat in the EU/EEA.
- Contract is non-exclusive and has uniform conditions for all participants.
- Submission of contract documents by 28.12.2024 for a start date of 01.02.2025.
Key facts
- Contract period
- Up to 24 months, ending no later than 31.01.2027.
- Evaluation
- This is not a public procurement in the sense of Directive 2014/24/EU, but a publication for transparency.
What it takes to qualify
Worth a closer look
- The tender is not a public procurement, so standard bid submission rules may not apply.
- The exact submission mode and envelope structure are not specified.
Experience
- At least 1 similar work — Experience as a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) for the drug Pegfilgrastim.
- Experience as a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) for the drug Pegfilgrastim.
Certifications and registrations
Pharmazeutischer Unternehmer statusMust be a pharmaceutical entrepreneur as defined by § 4 Abs. 18 AMG.
GST registration (optional)Not stated in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Contract documents and conditionsRequested from the contact address in the tender.